Alkermes just reported Q2 results, with progress around revenue growth from its product portfolio and some pipeline progress.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at ...

In this medical fiction tale, a veteran psychiatrist with narcolepsy forms a bond with an unsettling young girl just before a ...

St. Luke’s internal medicine specialist Arunmozhi Adavan, MD, explains the importance of choosing a primary care physician, ...

Takeda ( TOKYO:4502/NYSE:TAK) today announced earnings results for the first quarter of fiscal year 2025 (three months ended June 30, 2025), with generic erosion of VYVANSE significantly impacting ...